Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease

This study has been completed.
Sponsor:
Collaborator:
Alkermes, Inc.
Information provided by:
Endo Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00465959
First received: April 24, 2007
Last updated: December 3, 2013
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2007
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: December 3, 2013